Introduction

Non-invasive Prenatal Test (NIPT) is a safe and highly accurate test that only requires the collection of blood from pregnant women to test for fetal chromosomal abnormalities. In addition to the common trisomy disorders (Down syndrome, Edward syndrome, and Batau syndrome), we have also developed tests for microdeletion syndromes (NIPT2.0) and skeletal dysplasia-related mutations (NIPT3.0) to provide more comprehensive early screening programs.

Brochure

Features / strengths

• One-stop service with implementable programs in Taiwan.
  
• Certified by LDTS (TFDA), the testing quality is guaranteed.

Specification in detail

• NIPT1.0：Chromosomes 13, 18, 21 and sex chromosomes.
  
• NIPT2.0：22 pairs of autosomes, Sex chromosomes, and 20 microdeletion syndromes.
  
• NIPT3.0：22 pairs of autosomes, Sex chromosomes, 20 microdeletion syndromes, and Skeletal Dysplasia related 5 genes with 87 mutation hotspots.
  

Partnership wanted

Product Distribution ： Look for business partner and agency

＃Non-invasive Prenatal Tests(NIPTs)　　＃Maternal-Fetal Healthcare　　＃Precision Medicine